He added that Trump’s case is “probably the most analyzed case report” but that it is “just below the scale of the evidence we really need.”
He noted that clinical trials are the standard for whether they are effective.
“The real evidence of how good the drug is and what it will do on average should come from these large clinical trials, these randomized clinical trials, which are the gold standard. And that’s ongoing,” Schliefer said. “We’ve got some preliminary evidence that we’ve talked to the FDA, and we’re going for authorization for emergency use, because we think it’s appropriate at the moment.”
Trump, who was hospitalized at Walter Reed National Military Medical Center after being diagnosed with coronavirus, was treated with an experimental antibody drug and described it as a “cure.”
In an interview with Fox News host Maria Bertiromo on Sunday, Trump said he had beaten Kovid-19 and claimed immunity to the virus.
Asked by host Margaret Brennan on CBS if Regeneran’s drug builds immunity, Scliff said, “It does.”
“If you get it in our winter, if you do, it’ll probably last you months,” Scliffer said.
